Tue May 13 13:10:00 UTC 2025: Here’s a news article summarizing the provided text:

**FOR IMMEDIATE RELEASE**

**AvKARE Voluntarily Recalls Over-the-Counter Eye Products Due to Manufacturing Concerns**

**ATHENS, TN** – AvKARE, a pharmaceutical distributor, has initiated a voluntary recall of several over-the-counter ophthalmic products due to manufacturing deviations detected during a recent U.S. Food and Drug Administration (FDA) audit. The recall was prompted by notification from the recalling firm, BRS Analytical Services LLC, regarding potential quality issues.

According to AvKARE, the manufacturing deviations could result in products of unacceptable quality, making it impossible to rule out potential risks to patients who use the affected items. The specific health hazard associated with the recalled products remains unknown, but AvKARE is urging consumers to immediately discontinue use.

The recalled products were shipped between May 26, 2023, and April 21, 2025. A comprehensive list of affected products, including lot numbers and expiration dates, is available in a press release from AvKARE. A recall notice posted on the FDA’s website identified the amount of cases involved in the recall.

AvKARE is instructing customers who possess these recalled products to complete a Quality to Return form, downloadable as a PDF from the company’s recall notice, and fax it to 931-292-6229 or email it to customerservice@avkare.com. Upon receipt, AvKARE will issue a Return to Authorization Form, allowing customers to ship the recalled product back to the specified address for a full credit, including reimbursement of shipping costs.

AvKARE has notified the FDA of the recall and is working to ensure the safe and efficient removal of affected products from the market. Consumers with questions or concerns are encouraged to contact AvKARE directly. USA TODAY has reached out to AvKARE for further details.

Read More